• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.32% Nasdaq Down 0.62%

    Biogen Inc. (BIIB)

    -NasdaqGS
    274.99 Down 6.09(2.17%) Apr 29, 4:00PM EDT
    |After Hours : 272.62 Down 2.37 (0.86%) Apr 29, 6:37PM EDT
    Prev Close:281.08
    Open:278.24
    Bid:261.31 x 100
    Ask:283.52 x 100
    1y Target Est:345.67
    Beta:0.365881
    Earnings Date:Jul 22 - Jul 26 (Est.)
    Day's Range:271.39 - 280.53
    52wk Range:242.07 - 420.99
    Volume:1,941,004
    Avg Vol (3m):1,825,490
    Market Cap:60.24B
    P/E (ttm):17.93
    EPS (ttm):15.34
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBDown 2.17%60.24B
    PFEDown 0.61%202.54B
    ABTDown 3.76%57.31B

    Key Statistics

    Forward P/E (1 yr):13.65
    P/S (ttm):5.71
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :18.91
    Quarterly EPS Est (Jun-16) :4.66
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):1.54

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback